Skip to main content
Log in

Determinants of Aciclovir-Induced Nephrotoxicity in Children

  • Original Research Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Background: Aciclovir is the drug of choice for severe systemic herpes virus infections. Nephrotoxicity is one of the clinically significant adverse effects of this drug, but studies examining nephrotoxicity in children are scarce.

Objective: To identify risk factors for aciclovir-associated nephrotoxicity in the pediatric population.

Patients and methods: A retrospective review was conducted on all children (mean age 81 months; n = 126 [74 boys]) who were treated with aciclovir in a tertiary center between July 2005 and January 2006 and who met our inclusion criteria. Glomerular filtration rate (GFR) was calculated on the first day of treatment and at the peak measured creatinine level while on therapy, using Schwartz’s method.

Results: Aciclovir therapy was associated with a significant increase in serum creatinine levels and a parallel decrease in GFR (n = 93; both p ≤ 0.0001). Children with immunosuppression who received a variety of other nephrotoxic drugs exhibited more severe nephrotoxicity than those not receiving nephrotoxic drugs. In multiple regression analysis, the use of nephrotoxic drugs (p = 0.02) and impaired GFR at baseline (p = 0.04) were predictive for nephrotoxicity.

Conclusions: Within the recommended age-dependent dosage schedule of aciclovir there was no effect of dose per kg, age, or sex on nephrotoxicity. The predictors of aciclovir nephrotoxicity were the concomitant use of nephrotoxic drugs and impaired GFR at baseline.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II
Table III
Table IV
Table V
Table VI

Similar content being viewed by others

References

  1. Wasiewski WW, Fishman MA. Herpes simplex encephalitis: the brain biopsy controversy. J Pediatr 1988; 113: 575–8

    Article  PubMed  CAS  Google Scholar 

  2. Bryson YY. The use of acyclovir in children. Pediatr Infect Dis 1984; 3: 345–8

    Article  PubMed  CAS  Google Scholar 

  3. Balfour Jr HH. Intravenous acyclovir for varicella in immunocompromised children. J Pediatr 1984; 104: 134–6

    Article  PubMed  Google Scholar 

  4. Krieble BF, Rudy DW, Glick MR, et al. Acyclovir neurotoxicity and nephrotoxicity: the role for hemodialysis [case report]. Am J Med Sci 1993; 305: 36–9

    Article  PubMed  CAS  Google Scholar 

  5. Eck P, Silver SM, Clark EC. Acute renal failure and coma after a high dose of oral acyclovir. N Engl J Med 1991; 325: 1178–9

    Article  PubMed  CAS  Google Scholar 

  6. Keeney RE, Kirk LE, Bridgen D. Acyclovir tolerance in humans. Am J Med 1992; 73: 176–81

    Article  Google Scholar 

  7. Sawyer MH, Webb DE, Balow JE, et al. Acyclovir-induced renal failure: clinical course and histology. Am J Med 1988; 84: 1067–71

    Article  PubMed  CAS  Google Scholar 

  8. Bianchetti MG, Roduit C, Oetliker OH. Acyclovir-induced renal failure: course and risk factors. Pediatr Nephrol 1991; 5: 238–9

    Article  PubMed  CAS  Google Scholar 

  9. Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kid Dis 2005; 45: 804–17

    Article  PubMed  CAS  Google Scholar 

  10. Prazella MA. Drug induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci 2003; 325: 349–62

    Article  Google Scholar 

  11. Ahmad T, Simmonds M, Mclver AG, et al. Reversible renal failure in renal transplant patients receiving oral acyclovir prophylaxis. Pediatr Nephrol 1994; 8: 489–91

    Article  PubMed  CAS  Google Scholar 

  12. Vachvanichsanong P, Patamasucon P, Malagon M, et al. Acute renal failure in a child associated with acyclovir. Pediatr Nephrol 1995; 9: 346–7

    Article  PubMed  CAS  Google Scholar 

  13. Vomiero G, Blair C, Robb I, et al. Combination of ceftriaxone and acyclovir-an underestimated nephrotoxic potential? Pediatr Nephrol 2002; 17: 633–7

    Article  PubMed  Google Scholar 

  14. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 1987; 34: 571–90

    PubMed  CAS  Google Scholar 

  15. Kowalcvzyk AL, Dupuis LL, Domaratzki J. Acyclovir toxicity in pediatric patients: incidence and risk factor [abstract p-43]. Proceedings of the winter meeting of the American College of Clinical Pharmacy; 1991 Dec; Boston. Boston (MA): American College of Clinical Pharmacy, 1991

    Google Scholar 

  16. Koren G, Klein J, MacLeod M. The dissociation between aminoglycoside serum concentrations and nephrotoxicity. Life Sci 1988; 43: 1817–23

    Article  PubMed  CAS  Google Scholar 

  17. Koren G, Lau A, Kenyon CF, et al. Clinical course and pharmacokinetics following a massive overdose of amphotericin B in a neonate. Toxicol Clin Toxicol 1990; 28: 371–8

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the Canadian Institutes of Health Research (CIHR). G. Koren is the Ivey Chair in Molecular Toxicology, Department of Medicine, University of Western Ontario, Ontario, Canada.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gideon Koren.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schreiber, R., Wolpin, J. & Koren, G. Determinants of Aciclovir-Induced Nephrotoxicity in Children. Pediatr-Drugs 10, 135–139 (2008). https://doi.org/10.2165/00148581-200810020-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00148581-200810020-00008

Keywords

Navigation